![]() |
---|
KEYWORD | Aggregation Method | Secretion | |
---|---|---|---|
Whole Blood/Impedance | LTA/PRP | Luminescence | |
Anti-GP IIb/IIIa |
|
|
|
Antiplatelet |
|
|
|
Aspirin |
|
|
|
Bleeding |
|
|
|
Clopidogrel |
|
|
|
CPB |
|
|
|
Dual Antiplatelet |
|
||
Energy Drink |
|
||
Extracts |
|
||
Glanzmann's Thrombasthenia |
|
|
|
Hermansky-Pudlak |
|
|
|
HIT |
|
|
|
HIV |
|
||
Hyperaggregability |
|
|
|
Hyper-Sensitivity |
|
||
Hypotonic Shock |
|
||
Ibuprofen |
|
||
ISTH-BAT |
|
||
Menorrhagia |
|
|
|
Myelodysplasia |
|
|
|
Myeloperoxidase |
|
||
Myeloproliferative Disorders |
|
|
|
NSAID |
|
||
OPCAB |
|
||
Pediatric |
|
|
|
Prothrombitic |
|
|
|
Shape Change |
|
||
SSRIs |
|
|
|
Stroke |
|
||
Tamoxifen |
|
||
Thrombin Receptor Antagonist |
|
||
Thromboxane Receptor |
|
||
Uremia |
|
|
|
von Willebrand Factor |
|
|
|
Whole Blood-Lumi Evaluation |
|
|
|